BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2008
View Archived Issues
Manhattan successfully completes pre-IND meetings with FDA for Altoderm and Altolyn
Read More
Recent patents impart new oncolytic agents
Read More
FDA extends review period by three months for additional indication for antibiotic Doribax
Read More
AlphaMed successfully expresses a humanized version of alpha 1- antitrypsin
Read More
Pharmion's shareholders approve USD 2.9 billion acquisition of company by Celgene
Read More
ProStrakan receives Swedish marketing authorization for Rapinyl in breakthrough cancer pain
Read More
Recent UCB and Pierre Fabre patents report new compounds for treating neurological disorders
Read More
Novel therapeutic agents for gastrointestinal disorders described in recent patent literature
Read More
Beneficial effect of beclomethasone seen in patients with GI graft-versus-host disease
Read More
Favorable impact on survival seen with Neuradiab in malignant glioma
Read More
7TM enters metabolic disorder drug discovery collaboration with Dr. Reddy's
Read More
Anesiva submits sNDA for Zingo for needle insertion pain in adults
Read More
GSK cervical cancer candidate vaccine demonstrates long-term protection
Read More
KaloBios initiates phase I/II trial of KB-002 in persistent asthma
Read More
Neuroprotective synergy seen with lithium and valproic acid in vitro
Read More
Evidence links 5-HT2A-mGluR2 complex to psychosis
Read More
Zeria and Astellas co-develop and co-market Z-338 for functional dyspepsia in Japan
Read More
Oxford Biomedica completes enrolment in phase III TRIST study of Trovax in renal cancer
Read More
Lilly terminates Air insulin program for type 1 and type 2 diabetes
Read More
BioCancell submits pre-IND application to FDA for phase I clinical trials of BC-819 in cancer
Read More
Positive results from clinical phase I study of PL-3994 in congestive heart failure
Read More
Progen begins global phase III study of PI-88 in post-resection liver cancer
Read More
Genitope suspends development of MyVax personalized immunotherapy
Read More
Bionomis begins dose-finding preclinical study of its anti-anxiety candidate BNC-210
Read More
Avant completes merger of wholly owned subsidiary Callisto into Celldex
Read More
Sareum initiates in-house drug discovery program targeting the fatty acid synthase enzyme
Read More